M. D. Anderson study finds common diabetic therapy reduces risk of pancreatic cancer

Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreatic cancer by 62 percent, according to research from The University of Texas M. D. Anderson Cancer Centre, published in the 1 August issue of Gastroenterology...

Read the whole article on

More from